Investing in These Retailers' Stock is 'Worth the Risk,' JPMorgan Says — Positive

BBY  W   Investopedia — June 02, 2025

Best Buy and Wayfair stock offer a healthy balance of risk and reward, JPMorgan said.

image for news Investing in These Retailers' Stock is 'Worth the Risk,' JPMorgan Says

Nvidia: The Leader Reigns Supreme — Positive

NVDA   Seeking Alpha — June 02, 2025

Nvidia Corporation is delivering incredible revenue growth, driven by its leadership in powering the AI revolution despite recent China export restrictions. The surge in revenues has led to sizable profits and cash flow, helping to drive a buyback that's now bringing down the outstanding share count. NVDA stock trades at reasonable valuation given its superior projected revenue and earnings growth over the next several years.

image for news Nvidia: The Leader Reigns Supreme

Should GameStop Stock Be in Your Portfolio Pre-Q1 Earnings? — Neutral

GME   Zacks Investment Research — June 02, 2025

GME's Q1 results are likely to reflect y/y EPS growth despite falling sales, but valuation and fundamentals raise questions.

image for news Should GameStop Stock Be in Your Portfolio Pre-Q1 Earnings?

Phase 2 trial results continue to show clinically meaningful efficacy and durable responses, including 36.5-month median overall survival after four years of follow-up, with a manageable safety profile Findings presented today at ASCO 2025 and concurrently published in The Lancet Oncology For U.S. media and investors only DUBLIN , June 2, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term data, including the first report of median overall survival (OS) from the Phase 2 trial evaluating Ziihera® (zanidatamab-hrii), a dual HER2-targeted bispecific antibody, in combination with chemotherapy for the investigational use in first-line HER2-positive (IHC 3+ or IHC …

image for news Jazz Pharmaceuticals Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera® (zanidatamab-hrii) in First-Line HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ASCO 2025

Prosecutors aren't the only ones arguing for a smaller Google. Some critics say it might be better for investors, customers and innovation.

image for news What if Google Just Broke Itself Up? A Tech Insider Makes the Case.

Mission Produce Pre-Q2 Earnings Review: Buy Now or Stay Cautious? — Negative

AVO   Zacks Investment Research — June 02, 2025

AVO eyes Q2 gains from strong avocado pricing, blueberry volume growth and global sourcing agility amid near-term cost pressures and tariff uncertainties.

image for news Mission Produce Pre-Q2 Earnings Review: Buy Now or Stay Cautious?

Planet Fitness Up 11% in Three Months: Should You Buy, Sell or Hold? — Negative

PLNT   Zacks Investment Research — June 02, 2025

PLNT navigates near-term challenges with strategic growth move. Here is what investors should watch.

image for news Planet Fitness Up 11% in Three Months: Should You Buy, Sell or Hold?

Leidos Outperforms Market YTD: Is it the Right Time to Buy the Stock? — Positive

LDOS   Zacks Investment Research — June 02, 2025

LDOS stock is climbing on rising backlogs, improving earnings estimates, and a healthy solvency position.

image for news Leidos Outperforms Market YTD: Is it the Right Time to Buy the Stock?

Why Is Berkshire Hathaway B (BRK.B) Down 6.6% Since Last Earnings Report? — Negative

BRK-A  BRK-B   Zacks Investment Research — June 02, 2025

Berkshire Hathaway B (BRK.B) reported earnings 30 days ago. What's next for the stock?

image for news Why Is Berkshire Hathaway B (BRK.B) Down 6.6% Since Last Earnings Report?

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=151291&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

image for news Contact Levi & Korsinsky by June 16, 2025 to Join Class Action Against Zenas BioPharma, Inc. (ZBIO)

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Napco To Contact Him Directly To Discuss Their Options

image for news SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Napco Security Technologies

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151290&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.

image for news June 10, 2025 Deadline: Join Class Action Lawsuit Against Treace Medical Concepts, Inc. (TMCI) - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=151293&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.

image for news LPRO ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Open Lending Corporation - June 30, 2025 Deadline

Customers are Encouraged to Check Eligibility and Apply for Monthly Electric Discount OAKLAND, Calif. , June 2, 2025 /PRNewswire/ -- More than an estimated 150,000 additional Pacific Gas and Electric Company (PG&E) customers are now eligible for an 18% discount on their electric rate.

image for news Expanding Access: More PG&E Customers Eligible for 18% Electric Discount Under New Support Program Guidelines

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=151289&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.

image for news Securities Fraud Class Action Filed Against Ibotta, Inc. (IBTA) - Levi & Korsinsky Reminds Investors of June 16, 2025

ConnectM Provides Update to Stockholders on Buyout Group's Offer — Neutral

CNTM   GlobeNewsWire — June 02, 2025

MARLBOROUGH, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (OTC: CNTM) (“ConnectM” or the “Company”), a high-growth technology company on the leading edge of the modern energy economy, today issued an update to its stockholders regarding the recent buyout offer by a group of longstanding stockholders.

image for news ConnectM Provides Update to Stockholders on Buyout Group's Offer

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151295&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

image for news Lost Money on Organon & Co. (OGN)? Contact Levi & Korsinsky Before July 22, 2025 to Join Class Action

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=151296&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.

image for news Did You Lose Money on Civitas Resources, Inc. (CIVI)? Levi & Korsinsky Urges Investors to Act Before July 1, 2025

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Krispy Kreme, Inc. of Class Action Lawsuit and Upcoming Deadlines - DNUT

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=151292&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

image for news Canopy Growth Corporation (CGC) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of June 3, 2025 Deadline